211 related articles for article (PubMed ID: 26621342)
21. 25I-NBOMe related death in Australia: a case report.
Kueppers VB; Cooke CT
Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
[TBL] [Abstract][Full Text] [Related]
22. Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.
Andrade AF; Mamo SK; Gonzalez-Rodriguez J
Anal Chem; 2017 Feb; 89(3):1445-1452. PubMed ID: 28059498
[TBL] [Abstract][Full Text] [Related]
23. Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
Hermanns-Clausen M; Angerer V; Kithinji J; Grumann C; Auwärter V
Clin Toxicol (Phila); 2017 Sep; 55(8):922-924. PubMed ID: 28471280
[TBL] [Abstract][Full Text] [Related]
24. The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.
Lawn W; Barratt M; Williams M; Horne A; Winstock A
J Psychopharmacol; 2014 Aug; 28(8):780-8. PubMed ID: 24569095
[TBL] [Abstract][Full Text] [Related]
25. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A; Farrugia A; Raul JS; Kintz P
Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
[TBL] [Abstract][Full Text] [Related]
26. The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.
Kawahara G; Maeda H; Kikura-Hanajiri R; Yoshida KI; Hayashi YK
Forensic Toxicol; 2017; 35(2):369-375. PubMed ID: 28890736
[No Abstract] [Full Text] [Related]
27. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
28. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
[TBL] [Abstract][Full Text] [Related]
29. NBOMe designer drug exposures reported to Texas poison centers.
Forrester MB
J Addict Dis; 2014; 33(3):196-201. PubMed ID: 25115175
[TBL] [Abstract][Full Text] [Related]
30. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
[TBL] [Abstract][Full Text] [Related]
31. A fatal poisoning involving 25C-NBOMe.
Andreasen MF; Telving R; Rosendal I; Eg MB; Hasselstrøm JB; Andersen LV
Forensic Sci Int; 2015 Jun; 251():e1-8. PubMed ID: 25841303
[TBL] [Abstract][Full Text] [Related]
32. Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.
Lützen E; Holtkamp M; Stamme I; Schmid R; Sperling M; Pütz M; Karst U
Drug Test Anal; 2020 Apr; 12(4):465-471. PubMed ID: 31846172
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats.
Wojtas A; Herian M; Skawski M; Sobocińska M; González-Marín A; Noworyta-Sokołowska K; Gołembiowska K
Neurotox Res; 2021 Apr; 39(2):305-326. PubMed ID: 33337517
[TBL] [Abstract][Full Text] [Related]
34. A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
Schetz D; Schetz A; Kocić I
Biomed Pharmacother; 2022 Feb; 146():112295. PubMed ID: 34980551
[TBL] [Abstract][Full Text] [Related]
35. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Halberstadt AL
Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
[TBL] [Abstract][Full Text] [Related]
37. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.
Walterscheid JP; Phillips GT; Lopez AE; Gonsoulin ML; Chen HH; Sanchez LA
Am J Forensic Med Pathol; 2014 Mar; 35(1):20-5. PubMed ID: 24457586
[TBL] [Abstract][Full Text] [Related]
38. Experimental Study on the Postmortem Redistribution of the Substituted Phenethylamine, 25B-NBOMe.
Shintani-Ishida K; Saka K; Nakamura M; Yoshida KI; Ikegaya H
J Forensic Sci; 2018 Mar; 63(2):588-591. PubMed ID: 28643397
[TBL] [Abstract][Full Text] [Related]
39. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
Drug Enforcement Administration. Department of Justice
Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
[TBL] [Abstract][Full Text] [Related]
40. The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man.
Armenian P; Gerona RR
Am J Emerg Med; 2014 Nov; 32(11):1444.e3-5. PubMed ID: 24908444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
